GI Dynamics' EndoBarrier ™ Gastrointestinal Liner Demonstrates Significant HbA1c Reduction In Obese People Living With Type 2 Diabetes
Links shared publicly online about this topic.
- 1,606total visits
GI Dynamics' EndoBarrier ™ Gastrointestinal Liner Demonstrates Significant HbA1c Reduction In Obese People Living With Type 2 Diabetes
View full resource at medicalnewstoday.com
Tags: Gastroenterology, Diabetes, Type 2 Diabetes, Obesity
Most Recently Shared on November 13, 2009 at 5:35 am By:
GI Dynamics' EndoBarrier ™ Gastrointestinal Liner Demonstrates Significant HbA1c Reduction In Obese Peop.. http://bit.ly/10qLiR
Also Shared By:
Gastroenterology Article | Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
mdlinx.com — “Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients” View full resource at mdlinx.com
Most Recently Shared on October 7, 2011 at 11:10 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response i... http://t.co/8oEuSp3Y #GI
GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers - News Press Release | PharmiWeb.com
pharmiweb.com — “GI Dynamics, Inc. (ASX: GID), a company pioneering the development of effective non-surgical approaches for treating type 2 diabetes and obesity, announced today that shares in the company (in the form of CHESS Depositary Interests or CDIs) have” View full resource at pharmiweb.com
Most Recently Shared on September 7, 2011 at 7:35 am By:
Press Release: GI Dynamics Inc. Posted on:07 Sep 11 GI Dynamics, Inc. (ASX: GID), a company pioneering the devel... http://t.co/Q41IkOZ
GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 7, 2011 at 6:55 am By:
GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers: LEXINGTON… http://t.co/SELRcAp
GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers 07.09.2011 | Nachricht | finanzen.net
finanzen.net — “GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers 07.09.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on September 7, 2011 at 1:34 am By:
GI Dynamics Commences Trading on the ASX Following Successful A$80 Million Offers: GI Dynamics, Inc. (ASX: GID),... http://t.co/bQCG4gl
Australian IPO brings in $86 million for GI Dynamics - Related Stories - AdvaMed SmartBrief
smartbrief.com — “GI Dynamics has achieved its lower threshold of $86 million in an initial public offering in Australia. The Lexington, Mass.-based company last month received Australian approval for its EndoBarrier, which is designed to treat obesity and type 2 diabetes. ” View full resource at smartbrief.com
Most Recently Shared on August 31, 2011 at 11:48 pm By:
Gunter Wessels Health Marketing, PhD, and Doctor
Cool device-->Australian IPO brings in $86 million for GI Dynamics http://t.co/SIy4gtD
Medical device company GI Dynamics' backers confident of $80m float | The Australian
theaustralian.com.au — “IT'S no secret companies and bankers trying to get public floats away are having nervous nights.” View full resource at theaustralian.com.au
Most Recently Shared on August 23, 2011 at 3:34 am By:
Drugs and Devices OW OW Health
Medical device company GI Dynamics' backers confident of $80m float - The Australian: Medical device ... http://t.co/EvU243w #MedDevice
Implantable device may reverse type 2 diabetes - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “The EndoBarrier, a newly developed implantable sleeve, resulted in remission of type 2 diabetes in 72% of obese patients, experts at U.K.-based Musgrove Park Hospital found. The device, an incisionless alternative to duodenum switch, lines the duodenum and only allows food absorption into the lower…” View full resource at smartbrief.com
Most Recently Shared on August 8, 2011 at 5:20 pm By:
Implantable device may reverse type 2 #diabetes http://t.co/5DY8UkX #BioE #GI
Medtronic taking part in GI Dynamics private placement
medcitynews.com — “Medtronic will be one of the participants in a GI Dynamics private placement. Read more about what this maker of new innovative medical devices may do.” View full resource at medcitynews.com
Most Recently Shared on August 5, 2011 at 8:46 pm By:
Medtronic taking part in GI Dynamics private placement http://bit.ly/rtE6Fw
Gastroenterology Article | Ultrasonography
mdlinx.com — “A novel 3-D dynamic anorectal ultrasonography technique for the assessment of perineal descent, compared with defecography” View full resource at mdlinx.com
Most Recently Shared on July 25, 2011 at 8:53 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
A novel 3-D dynamic anorectal ultrasonography technique for the assessment of perineal descent, compared wit... http://bit.ly/qzXwzo #GI
GI Dynamics Receives Australian TGA Approval for the EndoBarrier® Gastrointestinal Liner for the Treatment of Type 2 Diabetes and Obesity | Business Wire
businesswire.com — “GI Dynamics, Inc. (GI Dynamics), a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of” View full resource at businesswire.com
Most Recently Shared on July 25, 2011 at 1:04 pm By:
GI Dynamics Receives Australian TGA Approval for the EndoBarrier® Gastrointestinal Liner for the Treatment of Ty... http://bit.ly/qAH5zm
EndoBarrier Triggers Beneficial Hormone Effects Leading To Rapid Glycemic Control, Weight Loss And Reduced Heart Disease Risk
medicalnewstoday.com — “GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrie” View full resource at medicalnewstoday.com
Most Recently Shared on March 30, 2011 at 11:27 pm By:
EndoBarrier Triggers Beneficial Hormone Effects Leading To Rapid Glycemic Control, Weight Loss And Reduced Heart... http://bit.ly/hmW53j
GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes
news-medical.net — “GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrier Gastrointestinal Liner on type 2 diabetes, weight loss and other metabolic factors.” View full resource at news-medical.net
Most Recently Shared on March 30, 2011 at 10:37 am By:
GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes: GI Dynamics, a leader i... http://bit.ly/fc9S92
Parkinson Disease on #MDlinx
mdlinx.com — “Parkinson Disease on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 19, 2010 at 1:44 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Minimal Detectable Change of the Timed “Up & Go†Test and the Dynamic Gait Index in People With Parkinson Di... http://bit.ly/a3giQR #neuro
Gastroenterology News & Articles - MDLinx - Magnetic Resonance Imaging on #MDlinx
mdlinx.com — “Gastroenterology News & Articles - MDLinx - Magnetic Resonance Imaging on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 23, 2010 at 8:51 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Dynamic contrast-enhanced MRI of neuroendocrine hepatic metastases: A feasibility study using a dual-input two-... http://bit.ly/buDxvA #GI
Gastroenterology News & Articles - MDLinx - Colorectal Neoplasms on #MDlinx
mdlinx.com — “Gastroenterology News & Articles - MDLinx - Colorectal Neoplasms on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 8, 2010 at 7:29 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Perfusion CT and US of Colorectal Cancer Liver Metastases: A Correlative Study of Two Dynamic Imaging Modalitie... http://bit.ly/d8g1yb #GI
Advertisement
Health Feed
@Health_Feed
#HEALTH GI Dynamics' EndoBarrier â„¢ Gastrointestinal Liner Demonstrates Significant HbA1c Reduction In Obese People ... http://ow.ly/161nlR
1 year ago...